CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements
{{output}}
Warfarin continues to be the mainstay therapy for preventing thrombus formation. Although pharmacogenetic algorithms have shown higher predictability of the optimal warfarin dose and lower occurrence of bleeding episodes, they often do not include ethno-specif... ...
